National Health Investors Inc (NHI) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 83.80
(+26.40%)
Based on the National Health Investors Inc stock forecast from 3 analysts, the average analyst target price for National Health Investors Inc is USD 83.80 over the next 12 months. National Health Investors Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of National Health Investors Inc is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, National Health Investors Inc’s stock price was USD 66.30. National Health Investors Inc’s stock price has changed by -2.57% over the past week, +0.12% over the past month and +24.32% over the last year.
No recent analyst target price found for National Health Investors Inc
No recent average analyst rating found for National Health Investors Inc
Company Overview National Health Investors Inc
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. Read Less
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and med...Read More
Frequently Asked Questions About National Health Investors Inc (NHI) Stock
Based on ratings from 3 analysts National Health Investors Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 3 hold ratings.
NHI stock's dividend yield is 5.20%.
Our analysis grades NHI stock's dividend yield at F. This means that NHI stock's dividend yield is above 50% of the stocks in the REIT - Healthcare Facilities sector in the NYE exchange.
Based on this NHI may be a average dividend stock for its sector.
Based on targets from 3 analysts, the average taret price for NHI is USD 83.80 over the next 12 months. The maximum analyst target price is USD 92 while the minimum anlayst target price is USD 72.
NHI stock's Price/Earning ratio is 23.82.
Our analysis grades NHI stock's Price / Earning ratio at B+. This means that NHI stock's Price/Earning ratio is above 11% of the stocks in the REIT - Healthcare Facilities sector in the NYE exchange.
Based on this NHI may be undervalued for its sector.
The last closing price of NHI's stock was USD 66.30.
The most recent market capitalization for NHI is USD 3.15B.
Based on targets from 3 analysts, the average taret price for NHI is projected at USD 83.80 over the next 12 months.
This means that NHI's stock price may go up by +26.40% over the next 12 months.
We can't find any ETFs which contains National Health Investors Inc's stock.
As per our most recent records National Health Investors Inc has 26 Employees.
National Health Investors Inc's registered address is 222 Robert Rose Drive, Murfreesboro, TN, United States, 37129-6346.
You can get more information about it from National Health Investors Inc's website at https://www.nhireit.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About National Health Investors Inc (NHI) Stock
Based on ratings from 3 analysts National Health Investors Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 3 hold ratings.
NHI stock's dividend yield is 5.20%.
Our analysis grades NHI stock's dividend yield at F. This means that NHI stock's dividend yield is above 50% of the stocks in the REIT - Healthcare Facilities sector in the NYE exchange.
Based on this NHI may be a average dividend stock for its sector.
Based on targets from 3 analysts, the average taret price for NHI is USD 83.80 over the next 12 months. The maximum analyst target price is USD 92 while the minimum anlayst target price is USD 72.
NHI stock's Price/Earning ratio is 23.82.
Our analysis grades NHI stock's Price / Earning ratio at B+. This means that NHI stock's Price/Earning ratio is above 11% of the stocks in the REIT - Healthcare Facilities sector in the NYE exchange.
Based on this NHI may be undervalued for its sector.
The last closing price of NHI's stock was USD 66.30.
The most recent market capitalization for NHI is USD 3.15B.
Based on targets from 3 analysts, the average taret price for NHI is projected at USD 83.80 over the next 12 months.
This means that NHI's stock price may go up by +26.40% over the next 12 months.
We can't find any ETFs which contains National Health Investors Inc's stock.
As per our most recent records National Health Investors Inc has 26 Employees.
National Health Investors Inc's registered address is 222 Robert Rose Drive, Murfreesboro, TN, United States, 37129-6346.
You can get more information about it from National Health Investors Inc's website at https://www.nhireit.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NHI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
